share_log
  • Headlines
  • Zhejiang Jolly Pharmaceutical (300181.SZ) released the performance for the first three quarters, with a net income of 0.421 billion yuan, a year-on-year increase of 46.93%.

佐力药业(300181.SZ)发前三季业绩，净利润4.21亿元，同比增长46.93%

Zhejiang Jolly Pharmaceutical (300181.SZ) released the performance for the first three quarters, with a net income of 0.421 billion yuan, a year-on-year increase of 46.93%.

Zhitong Finance ·  Oct 27 18:40

Zhejiang Jolly Pharmaceutical (300181.SZ) released the third quarter report for 2024, with the company achieving revenue during the reporting period...

Finance and Economics APP reports that Zhejiang Jolly Pharmaceutical (300181.SZ) released the third quarter report for 2024, with the company achieving revenue of 2.045 billion yuan, a year-on-year increase of 39.59%; net income attributable to shareholders of the listed company is 0.421 billion yuan, a year-on-year increase of 46.93%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses is 0.415 billion yuan, a year-on-year increase of 47.80%; basic earnings per share is 0.6018 yuan/share.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated